Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. WMT
2. JMKE
3. ROST
4. NVDA
5. AAP
6. SPY
7. BABA
8. REF
9. TSLA
10. AVGO

Go back to Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial
iShares Diversified Alternatives Trust (NASDAQ: ALT) Delayed: 3.11 --0 (-0%)
Previous Close $3.11    52 Week High $54.24 
Open $3.11    52 Week Low $48.35 
Day High $3.11    P/E N/A 
Day Low $3.11    EPS $0.00 
Volume 230